CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 157 filers reported holding BEAM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.8%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,020,911
-18.7%
541,410
+8.0%
0.00%
-20.0%
Q2 2023$16,010,341
+12.8%
501,420
+8.2%
0.01%
+25.0%
Q1 2023$14,195,861
-21.3%
463,614
+0.5%
0.00%
-33.3%
Q4 2022$18,035,733
-16.2%
461,154
+2.0%
0.01%
-25.0%
Q3 2022$21,529,000
+39.9%
451,907
+13.7%
0.01%
+60.0%
Q2 2022$15,386,000
-27.6%
397,449
+7.2%
0.01%
-16.7%
Q1 2022$21,254,000
-23.3%
370,916
+6.6%
0.01%
-25.0%
Q4 2021$27,719,000
-4.5%
347,824
+4.3%
0.01%
-11.1%
Q3 2021$29,020,000
-10.3%
333,520
+32.6%
0.01%
-18.2%
Q2 2021$32,363,000
+84.0%
251,442
+14.5%
0.01%
+83.3%
Q1 2021$17,585,000
+5.7%
219,692
+7.9%
0.01%
-14.3%
Q4 2020$16,629,000
+293.8%
203,682
+18.8%
0.01%
+250.0%
Q3 2020$4,223,000
+82.6%
171,511
+107.6%
0.00%
+100.0%
Q2 2020$2,313,000
+393.2%
82,602
+217.6%
0.00%
Q1 2020$469,00026,0050.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders